Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro.
Antimicrob Agents Chemother
; 61(4)2017 04.
Article
em En
| MEDLINE
| ID: mdl-28115355
ABSTRACT
A number of inhibitors of the essential Mycobacterium tuberculosis mycolic acid transporter, MmpL3, are currently under development as potential novel antituberculosis agents. Using the checkerboard method to study the interaction profiles of various antituberculosis drugs or experimental compounds with two different chemotypes inhibiting this transporter (indolcarboxamides and adamantyl ureas), we showed that MmpL3 inhibitors act synergistically with rifampin, bedaquiline, clofazimine, and ß-lactams.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteínas de Membrana Transportadoras
/
Antituberculosos
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article